Acetylcholine esterase protects LDL against oxidation

被引:30
作者
Fuhrman, B
Partoush, A
Aviram, M [1 ]
机构
[1] Technion Israel Inst Technol, Fac Med, Rappaport Family Inst Res Med Sci, Lipid Res Lab, Haifa, Israel
[2] Rambam Med Ctr, Haifa, Israel
关键词
acetylcholine esterase; paraoxonase; LDL; HDL; lipid peroxides;
D O I
10.1016/j.bbrc.2004.08.019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Acetylcholine esterase (AChE) and paraoxonase 1 (PON1) are both serum ester hydrolases, which are associated with the prevalence of myocardial infarction. Both genes are located in close proximity on chromosome 7q21-22. As PON1 was suggested to protect against cardiovascular diseases secondary to its ability to break down oxidized lipids and to inhibit LDL oxidation, we examined AChE capacity to protect LDL against oxidation. Preincubation of LDL with AChE retarded the onset of copper ion-induced LDL oxidation in a concentration-dependent manner. AChE significantly reduced the formation of lipid peroxides and TBARS during the course of LDL oxidation, by up to 45%. This effect was associated with AChE-mediated hydrolysis of lipid peroxides, which accounts for the inhibition in the onset of LDL oxidation, the oxidative propagation phase, and aldehyde formation. We conclude that AChE, similar to PON1, can hydrolyze lipid peroxides and thus may prevent the accumulation of oxidized LDL and attenuate atherosclerosis development. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:974 / 978
页数:5
相关论文
共 28 条
[1]   Paraoxonase and acetylcholinesterase activities in humans exposed to organophosphorous compounds [J].
Akgür, SA ;
Öztürk, P ;
Sözmen, EY ;
Delen, Y ;
Tanyalçin, T ;
Ege, B .
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A, 1999, 58 (08) :469-474
[2]   PLASMA-LIPOPROTEIN SEPARATION BY DISCONTINUOUS DENSITY GRADIENT ULTRA-CENTRIFUGATION IN HYPERLIPOPROTEINEMIC PATIENTS [J].
AVIRAM, M .
BIOCHEMICAL MEDICINE, 1983, 30 (01) :111-118
[3]   Does paraoxonase play a role in susceptibility to cardiovascular disease? [J].
Aviram, M .
MOLECULAR MEDICINE TODAY, 1999, 5 (09) :381-386
[4]   Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions - PON1 esterase and peroxidase-like activities [J].
Aviram, M ;
Hardak, E ;
Vaya, J ;
Mahmood, S ;
Milo, S ;
Hoffman, A ;
Billicke, S ;
Draganov, D ;
Rosenblat, M .
CIRCULATION, 2000, 101 (21) :2510-2517
[5]   Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants [J].
Aviram, M ;
Rosenblat, M ;
Billecke, S ;
Erogul, J ;
Sorenson, R ;
Bisgaier, CL ;
Newton, RS ;
La Du, B .
FREE RADICAL BIOLOGY AND MEDICINE, 1999, 26 (7-8) :892-904
[6]   Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions - A possible peroxidative role for paraoxonase [J].
Aviram, M ;
Rosenblat, M ;
Bisgaier, CL ;
Newton, RS ;
Primo-Parmo, SL ;
La Du, BN .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (08) :1581-1590
[7]  
Aviram M, 2001, METHOD ENZYMOL, V335, P244
[8]   Polyphenolic flavonoids inhibit macrophage-mediated oxidation of LDL and attenuate atherogenesis [J].
Aviram, M ;
Fuhrman, B .
ATHEROSCLEROSIS, 1998, 137 :S45-S50
[9]  
Aviram M, 2000, FREE RADICAL RES, V33, pS85
[10]   CHARACTERIZATION OF THE ASSOCIATION OF ELECTROPHORUS-ELECTRICUS ACETYLCHOLINESTERASE WITH SPHINGOMYELIN LIPOSOMES - RELEVANCE TO COLLAGEN-SPHINGOMYELIN INTERACTIONS [J].
COHEN, R ;
BARENHOLZ, Y .
BIOCHIMICA ET BIOPHYSICA ACTA, 1984, 778 (01) :94-104